Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism DCN1 inhibitors(Defective cullin neddylation protein 1 inhibitors), UBE2M inhibitors(ubiquitin conjugating enzyme E2 M inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperplasia | Discovery | - | 21 Dec 2023 | |
Neoplasms | Discovery | - | 21 Dec 2023 |